Bio-Path Holdings (BPTH US)

Bio-Path Holdings, Inc. operates as a holding company. The Company, through its subsidiaries, develops novel cancer therapeutics for acute myeloid leukemia (AML), chronic myeloid leukemia (CML), and other challenging cancers. Bio-Path Holdings serves patients in the State of Texas.